Literature DB >> 31295537

Metal salts with low oral bioavailability and considerable exposures from ubiquitous background: Inorganic aluminum salts as an example for issues in toxicity testing and data interpretation.

Wolfgang Dekant1.   

Abstract

Oral administration is the preferred route of exposure for non-volatile chemicals with potential environmental exposures. For metal salts, systemic doses in such toxicity testing are often low due to limited oral bioavailability. Issues arising from the low bioavailability for toxicity testing and risk characterization are illustrated using aluminum (Al) salts as example. Al-cations have an oral bioavailability of below 1% and applicable doses are limited resulting in low systemic doses. Consequently, the low systemic doses are insufficient to induce clear adverse effects that may serve as points of departure for risk characterization.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aluminum; Oral bioavailability; Risk characterization; Toxicity testing

Mesh:

Substances:

Year:  2019        PMID: 31295537     DOI: 10.1016/j.toxlet.2019.07.013

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  2 in total

1.  Innovative In Vitro Strategy for Assessing Aluminum Bioavailability in Oral Care Cosmetics.

Authors:  Giorgia Allaria; Giulia De Negri Atanasio; Tommaso Filippini; Federica Robino; Lorenzo Dondero; Francesco Soggia; Francesca Rispo; Francesca Tardanico; Sara Ferrando; Stefano Aicardi; Ilaria Demori; Jan Markus; Katia Cortese; Matteo Zanotti-Russo; Elena Grasselli
Journal:  Int J Environ Res Public Health       Date:  2022-07-30       Impact factor: 4.614

2.  Rapamycin nanoparticles improves drug bioavailability in PLAM treatment by interstitial injection.

Authors:  Yahong Shi; Chuqiao Jiao; Xi Lu; Yifeng Nie; Xiang Li; Dong Han
Journal:  Orphanet J Rare Dis       Date:  2022-09-09       Impact factor: 4.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.